Medpace Holdings (MEDP) Change in Account Payables (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Change in Account Payables came in at -$129000.0 in Q2 2026, down 109.92% on a YoY basis from $1.3 million in Q2 2025, and down 253.57% quarter-over-quarter from $84000.0 in Q1 2026.
Analysis
Medpace Holdings (MEDP) Change in Account Payables (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Change in Account Payables for 12 consecutive years, with -$129000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Account Payables fell 109.92% year-over-year to -$129000.0; the trailing twelve-month figure through Jun 2026 stood at -$9.4 million (down 182.0% YoY), and the FY2025 full-year result was $2.6 million, up 188.67% from the prior year.
- Change in Account Payables fell to -$129000.0 in Q2 2026 per MEDP's latest filing, from $84000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $10.7 million in Q1 2025 and bottomed at -$10.7 million in Q3 2025.
- Historically, Change in Account Payables has averaged $394500.0 across 5 years, with a median of $74000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables soared 2093.31% in 2022, then plunged 1761.98% in 2025.
- Over 5 years, Change in Account Payables stood at $5.7 million in 2022, then sank by 65.17% to $2.0 million in 2023, then slumped by 96.75% to $64000.0 in 2024, then jumped by 1982.81% to $1.3 million in 2025, then sank by 109.68% to -$129000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$129000.0, $84000.0, and $1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -129,000.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 821,000.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -16.70 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -1.43 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 872,116.56 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -400,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -129,000.00 |
| Mar 31, 2026 | 84,000.00 |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | -10.73 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 10.72 Mn |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | -576,000.00 |
| Jun 30, 2024 | 4.90 Mn |
| Mar 31, 2024 | -7.35 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Sep 30, 2023 | -3.26 Mn |
| Jun 30, 2023 | -2.12 Mn |
| Mar 31, 2023 | 4.46 Mn |
| Dec 31, 2022 | 5.66 Mn |
| Sep 30, 2022 | -1.78 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Mar 31, 2022 | -1.04 Mn |
| Dec 31, 2021 | -284,000.00 |
| Sep 30, 2021 | 2.42 Mn |